Doctor's Guide to TGA Approved Medicinal Cannabis Indications

An RACGP approved introductory course for doctors in Australia to prescribe medicinal cannabis for approved clinical indications, and manage patient's with high standards of care.

About the course

This RACGP approved course is an introductory guide for medical practitioners on prescribing cannabinoid-based medicines. It covers approved clinical indications in Australia such as chronic pain, palliative care, multiple sclerosis, epilepsy, and CINV, based on TGA guidance documents. The course also teaches best practices for patient management, prescribing processes, current legislation, and adhering to TGA requirements to ensure high standards of patient care. Upon completion, you will receive a statement of attendance which you can use to become an authorised prescriber.

After this course, you will be able to:

Explain the anatomy, physiology and pathophysiology of the endocannabinoid system of the human body

Evaluate the clinical indications, contraindications, and side effects of cannabinoid-based medicines in General Practice

Differentiate appropriate cannabinoid-based treatment approaches, dosing strategies and titration protocols

Design appropriate patient management plan aligned with the current evidence-based research and the TGA legislation

Explain the TGA patient access pathways, and the process for prescribing the medicinal cannabis

Subscribe & Save

Become a member and get access to this course and all other education products

Starting from

$45.00 /month

Start 7 day trial

Self paced online course

One time payment

$299.95 Enrol now

Claim 4 CPD Hours

Medihuanna is a CPD approved education provider, and this activity has been approved by the RACGP (Activity ID: 414210). Upon completing this activity, you will be eligible to claim CPD hours. The activity will include the following CPD allocation which will be uploaded to the RACGP dashboard.

Educational Activities:

4.0 hours


Course Curriculum

Understanding medicinal cannabis and the current landscape in Australia
Section 1: The Cannabis Plant (7 min)
Section 2: The Endocannabinoid System (14 min)
Section 3: Pharmacology and Phytocannabinoids (32 min)
Section 4: Clinical Indications (68 min)
Section 5: Adverse Effects and Potential Drug Interactions of Cannabis (23 min)
Section 6: Treatment Considerations (30 min)
Section 7: Dosing & Titration (30 min)
Section 8: Patient Management and Monitoring (20 min)
Section 9: Patient Access (20 min)
Section 10: TGA Application Process (10 min)

Still have a question?

Your Queries Matter to Us: Get Expert Answers.
Co-Founder and Medical Director

Dr. Teresa Towpik

Co-Founder and Medical Director

About the Educator

Dr. Teresa Towpik has been a General Practitioner in Australia since 1993 and an advocate of medicinal cannabis since the law was amended and cannabis was legalized for medicinal use. In 2016 she founded Medihuanna with the goal to educate medical practitioners to safely treat patients with medicinal cannabis. Since then, she has been studying the therapeutic properties of cannabis, how it works, and the potential applications in General Practice, especially in the management of chronic debilitating pain.

Are you prescribing yet?

Expand your practice and treat your patients more holistically.

Get started for free